Virtual BELNUC’21 Symposium

Virtual BELNUC Symposium 2021

Online one-day symposium on May 8th, 2021

 

A virtual one-day symposium on May 8th 2021

Replacing the Antwerp ’21 in-person symposium, we are happy to announce a one-day virtual-only meeting on May 8th 2021.
Registration is free for BELNUC members but mandatory in order to receive your login credentials. Non-members can register for €100.

Register now using the link below before the registration deadline of May 5th 2021.

Click here to start your Registration 

Programme

Bone SPECT/CT: Joint forces in joint disease 09:00 – 09:30 Knives out: Operative techniques in foot and ankle surgery S. Desmyter
09:30 – 10:00 Seeing is believing: SPECT/CT in foot and ankle pain G. Gnanasegaran
10:00 – 10:30 Extinguishing the fire: radiosynoviorthesis in joint synovitis K. Liepe
Young Nuclearist Challenge 11:00 – 11:10 Solitary intense striatal hypermetabolism in candida encephalitis. D. Van Weehaeghe
11:10 – 11:20 18F-FDG PET/CT reveals an Epithelioid Angiosarcoma of the Superior Vena Cava Manifesting as a Large N. Ahmadi
11:20 – 11:30 MEN-1 and hibernoma: a serendipitous association? L. Guillaume
11:30 – 11:40 Painful ophthalmoplegia in a patient with a history of marginal zone lymphoma. C. Van Bogaert
11:40 – 11:50 Recurrent “occult” 18F-FDG uptake in an atypical case of antineutrophil cytoplasmic antibody-associated vasculitis. A. Castiaux
11:50 – 12:00 Small, but brave. L. De Mey
12:00 – 12:10 Fever of unknown origin: the quest for the crown. A. Deleu
12:10 – 12:20 Case of insulinoma treated with PRRT. G. O. Wetshosele
12:20 – 12:30 A remarkable discrepancy between 68Ga-PSMA and 18F-FDG PET/CT in a patient with metastatic castration-resistant prostate cancer. J. Gebruers
Oncology Update 14:00 – 14:45 Novel fluor-based PET tracers in oncology C. Deroose
14:45 – 15:30 Lung cancer and immunotherapy: How to read a PET-CT? N. Aide
Challenges in the reimbursement of rapid evolving technologies
(Ethics & Economy)
16:00 – 16:25 Nomenclature and revision of it: impact on nuclear medicine? B. de Haes
16:25 – 16:50 From innovation to routine clinical use, a health technology assessment perspective. F. Hulstaert
16:50 – 17:30 Nuclear medicine within hospital networks: opportunities in the short and long terms M. van Uytven
17:30 – 17:45 General Discussion

 

11:00 – 11:30 New challenges and achievements in F18 radiochemistry G. Bormans
Radiopharmacy break-out session 11:30 – 12:00 Radiobiology for targeted radionuclide therapy J. Nonnekens
12:00 – 12:30 Difference between IMP an non-IMP clinical studies with radiopharmaceuticals S. De Lombaerde

 

11:00 – 11:30 The future of EARL R. Boellaard
Physicist
break-out session
11:30 – 12:00 Standardization of absolute SPECT / CT quantization S.Peters
12:00 – 12:30 From the lab to the hospital – standards for radionuclide calibrators J. Paepen

Industry satellite symposium

To be announced
12:30 – 13:00 To be announced

Virtual Poster Area









Poster Area
Keeping up appearances may cause harm: a breast-implant induced anaplastic large cell lymphoma appearing on [18F]FDG-PET/CT. S. Vermeulen
Evaluation of myocardial uptake of Radium-223 during Xofigo® radiopharmaceutical treatment in a patient with metastatic prostate cancer and cardiac amyloidosis: a case study. M. Manley
Soft-tissue sarcoma mimicking prostate cancer progression evidenced on 68Ga-PSMA-11 PET/CT Q. Ahmed Shagera
C(AVE)AT A. Geysen
Axillary lymph node activation induced by COVID-19 vaccination on FDG PET/CT in a patient with a history of aggressive relapsing lymphoma. P. Moyaert
FDG-PET demonstrating the tip of the iatrogenic iceberg C. Van Keerberghen
Another differential diagnosis for lymphoma: Rosai-Dorfman syndrome G. Lens
COVID-19 Post-Vaccinal Lymphadenopathy Mimicking Lymph Node Metastases From Breast Neoplasia F. Fokoue
Suspicious thyroid cold nodule with intense focal 68Ga-DOTATATE uptake: a case report R. Manta
18F-FDG positive brain lesions in a metastatic patient: always think twice! C. Van Keerberghen
A perfect PMR pattern on FDG PET L. Boeckxstaens

Continuing education credits

The BELNUC ’21 Virtual symposium has been accredited with the following continuing education credits:

FANC/AFCN

  • 03h00 for nuclear medicine physicians
  • 01h30 for physicists qualified in nuclear medicine
  • 02h00 for radiopharmacists

RIZIV/INAMI

  • 4.5 CP (21002007; category 3; granted)
  • 2.0 CP (21002014; category 6; requested)

Please note that credits are only available when following the symposium live on the day of broadcast.

Young Nuclearist Challenge 2021

Back by popular demand: the Young Nuclearist Challenge 2021 will feature interesting case reports and you will help decide who wins the first prize of €300!